---
$id: https://graph.org.ai/products/commodity/51151523
$type: Product
source: UNSPSC
code: "51151523"
title: "Distigmine"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Distigmine

**UNSPSC Code**: 51151523
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinesterase inhibitor with the molecular formula C22H32N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T940307O7B, chemically known as 3,3-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) dibromide but generally known as distigmine, which bears US NIH Compound Identifier 27522. European Medicines Agency schedules Distigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01797MIG. World Health Organization schedules distigmine in its Anatomical Therapeutic Chemical (ATC) Classification. DISTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DISTIGMINE remains the US FDA Preferred Term for this commodity. SMILES: BR.BR.O(C(=O)N(CCCCCCN(C)C(=O)OC1C[N](CCC1)C)C)C1C[N](CCC1)C. .

